Rare regional pharma IPO points to Brazil recovery

Rare regional pharma IPO points to Brazil recovery

The São Paulo and New York offices of Davis Polk & Wardwell LLP; Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados in São Paulo and Estudio Garrido Abogados in Buenos Aires have helped Uruguay-based pharma company Biotoscana raise 1.3 billion reais (US$427 million) via an initial public offering (IPO) in Brazil.

Unlock unlimited access to all Latin Lawyer content